Phreesia Inc delivered a Q4 2025 result set that shows robust gross margins and improving cash generation, underscoring the strength of its SaaS-based patient intake and payments platform in the healthcare sector. Revenue for QQ4 2025 reached $109.7 million, up 15.5% year-over-year and 2.7% quarter-over-quarter, while gross profit rose to $76.1 million, yielding a gross margin of approximately 69.4%. Despite the top-line momentum, the company reported a net loss of $6.39 million and negative operating income of $7.61 million, reflecting sustained investment in R&D and go-to-market initiatives. EBITDA was positive at $2.14 million with an EBITDA margin around 1.95%, suggesting early profitability momentum at the operating level but ongoing SG&A and development investments weigh on the bottom line.